AIDS and Behavior

, Volume 15, Issue 2, pp 396–406

Malaise, Motivation and Motherhood: Predictors of Engagement in Behavioral Interventions from a Randomized Controlled Trial for HIV+ Women in Drug Abuse Recovery

  • Victoria B. Mitrani
  • Daniel J. Feaster
  • Nomi S. Weiss-Laxer
  • Brian E. McCabe
Original Paper


Drug abuse has serious consequences for the wellbeing of persons with HIV/AIDS but suboptimal rates of client engagement limit the efficacy of interventions. The present study examines and compares client characteristics that predicted engagement (defined as attendance at two or more sessions) in a family intervention (SET) and a group intervention within a randomized trial aimed at preventing relapse and improving medication adherence for 126 predominantly African American HIV+ women in drug abuse recovery. Intervention engagement (60% overall) was not significantly different across the two interventions. Fewer physical and mental symptoms (malaise) (P < 0.05), living independently (P < 0.05), living with children (P < 0.05), and readiness to change (P < 0.05) were associated with engagement across the two interventions. Results from this study can be used to inform outreach and engagement approaches for women dually affected by drug abuse and HIV/AIDS.


HIV/AIDS Drug abuse Engagement Women 


  1. 1.
    Klinkenberg WD, Sacks S, HIV/AIDS Treatment, Adherence, and Health Outcomes and Cost Study Group. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16:S22–42.CrossRefPubMedGoogle Scholar
  2. 2.
    Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27:251–9.PubMedGoogle Scholar
  3. 3.
    Sherbourne C, Forge NG, Kung FY, Orlando M, Tucker J. Personal and psychosocial characteristics associated with psychiatric conditions among women with human immunodeficiency virus. Womens Health Issues. 2003;13:104–10.CrossRefPubMedGoogle Scholar
  4. 4.
    Calsyn RJ, Klinkenberg WD, Morse GA, Miller J, Cruthis R, HIV/AIDS Treatment, Adherence, Health Outcomes and Cost Study Group. Recruitment, engagement, and retention of people living with HIV and co-occurring mental health and substance use disorders. AIDS Care. 2004;16:S56–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Compton WM, Glantz M, Delany P. Addiction as a chronic illness—putting the concept into action. Eval Program Plan. 2003;26:353–4.CrossRefGoogle Scholar
  6. 6.
    Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29:9–53.CrossRefGoogle Scholar
  7. 7.
    Copello AG, Templetonb L, Vellemanb R. Family interventions for drug and alcohol misuse: is there a best practice? Curr Opin Psychiatry. 2006;19:271–6.CrossRefPubMedGoogle Scholar
  8. 8.
    HIV/AIDS Treatment Adherence, Health Outcomes, Cost Study Group. The HIV/AIDS treatment adherence, health outcomes, and cost study: conceptual foundations and overview. AIDS Care. 2004;16:6–21.CrossRefGoogle Scholar
  9. 9.
    Andersen M, Hockman E, Smereck G, et al. Retaining women in HIV medical care. J Assoc Nurses AIDS Care. 2007;18:33–41.CrossRefPubMedGoogle Scholar
  10. 10.
    Pillai NV, Kupprat SA, Halkitis PN. Impact of service delivery model on health care access among HIV-positive women in New York City. AIDS Patient Care. 2009;23:51–8.CrossRefGoogle Scholar
  11. 11.
    Winiarski MG, Beckett E, Salcedo J. Outcomes of an inner-city HIV mental health programme integrated with primary care and emphasizing cultural responsiveness. AIDS Care. 2005;17:747–56.CrossRefPubMedGoogle Scholar
  12. 12.
    Mitrani VB, Szapocznik J, Robinson C. Structural ecosystems therapy with seropositive African American mothers. In: Pequegnat W, Szapocznik J, editors. Inside families: the role of families in preventing and adapting to HIV/AIDS. Rockville: National Institute of Mental Health; 2000. p. 243–80.Google Scholar
  13. 13.
    Mitrani V, Robinson C, Szapocznik J. Structural ecosystems therapy (SET) for women with HIV/AIDS. In: Stanton M, Bray J, editors. Handbook of family psychology. West Sussex: Wiley-Blackwell; 2009. p. 355–69.CrossRefGoogle Scholar
  14. 14.
    Szapocznik J, Feaster DJ, Mitrani VB, et al. Structural ecosystems therapy for HIV-seropositive African American women: effects on psychological distress, family hassles, and family support. J Consult Clin Psychol. 2004;72:288–303.CrossRefPubMedGoogle Scholar
  15. 15.
    Feaster DJ, Burns MJ, Brincks AB, et al. Relative efficacy of structural ecosystems therapy in reducing risk of drug abuse relapse for HIV+ African American women. Fam Process. In press.Google Scholar
  16. 16.
    Feaster DJ, Mitrani VB, Burns MJ, et al. A randomized controlled trial of structural ecosystems therapy for HIV medication adherence and substance abuse relapse prevention. Drug Alcohol Depend. In press.Google Scholar
  17. 17.
    Lefforge NL, Donohue B, Strada MJ. Improving session attendance in mental health and substance abuse settings: a review of controlled studies. Behav Ther. 2007;38:1–22.CrossRefPubMedGoogle Scholar
  18. 18.
    Stanton MD. Getting reluctant substance abusers to engaged in treatment/self-help: a review of outcomes and clinical options. J Marital Fam Ther. 2004;4:165–82.CrossRefGoogle Scholar
  19. 19.
    Cleary M, Hunt GE, Matheson SL, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev. 2008;1:Art. No.: CD001088. doi:10.1002/14651858.CD001088.pub2.
  20. 20.
    Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47:449–58.CrossRefPubMedGoogle Scholar
  21. 21.
    Prado G, Szapocznik J, Mitrani VB, Mauer MH, Smith L, Feaster DJ. Factors influencing engagement into interventions for adaptation to HIV in African American women. AIDS Behav. 2002;6:141–51.CrossRefPubMedGoogle Scholar
  22. 22.
    Chesney MA, Chambers DB, Taylor JM, Johnson LM, Folkman S. Coping effectiveness training for men living with HIV: results from a randomized clinical trial testing a group-based intervention. Psychosom Med. 2003;65:1038–46.CrossRefPubMedGoogle Scholar
  23. 23.
    Antoni MH, Carrico AW, Durán RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143–51.CrossRefPubMedGoogle Scholar
  24. 24.
    Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729–36.CrossRefPubMedGoogle Scholar
  25. 25.
    Padgett DK, Henwood B, Abrams C, Davis A. Engagement and retention in services among formerly homeless adults with co-occurring mental illness and substance abuse: voices from the margins. Psychiatr Rehabil J. 2008;31:226–33.CrossRefPubMedGoogle Scholar
  26. 26.
    Brown VB, Melchior LA, Panter AT, Slaughter R, Huba GJ. Women’s steps of change and entry into drug abuse treatment: a multidimensional stages of change model. J Subst Abuse Treat. 2000;18:231–40.CrossRefPubMedGoogle Scholar
  27. 27.
    DiClemente CC, Schlundt D, Gemmell L. Readiness and stages of change in addiction treatment. Am J Addict. 2004;13:103–19.CrossRefPubMedGoogle Scholar
  28. 28.
    Barroso J, Sandelowski M. Substance abuse in HIV-positive women. J Assoc Nurses AIDS Care. 2004;15:48–59.CrossRefPubMedGoogle Scholar
  29. 29.
    Wilke DJ, Kamata A, Cash SJ. Modeling treatment motivation in substance-abusing women with children. Child Abuse Negl. 2005;29:1313–23.CrossRefPubMedGoogle Scholar
  30. 30.
    Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47:597–606.CrossRefPubMedGoogle Scholar
  31. 31.
    Mellins CA, Kang E, Leu C-S, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care STDS. 2003;17:407–16.CrossRefPubMedGoogle Scholar
  32. 32.
    Leaver CA, Bargh G, Dunn JR. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11:S85–100.CrossRefGoogle Scholar
  33. 33.
    Szapocznik J, Kurtines WM. Breakthroughs in family therapy with drug abusing and problem youth. New York: Springer; 1989.Google Scholar
  34. 34.
    Minuchin S, Fishman HC. Family therapy techniques. Cambridge: Harvard University Press; 1981.Google Scholar
  35. 35.
    Szapocznik J, Hervis O, Schwartz S. Brief strategic family therapy for adolescent drug abuse. NIDA therapy manuals for drug addiction, manual 5. Rockville: US Department of Health and Human Services; 2003.Google Scholar
  36. 36.
    Baker SA, Beadnell B, Stoner S, et al. Skills training versus health education to prevent STDs/HIV in heterosexual women: a randomized controlled trial utilizing biological outcomes. AIDS Educ Prev. 2003;15:1–14.CrossRefPubMedGoogle Scholar
  37. 37.
    Mitrani VB, Prado G, Feaster DJ, Robinson-Batista C, Szapocznik J. Relational factors and family treatment engagement among low-income, HIV+ African American mothers. Fam Process. 2003;42:31–45.CrossRefPubMedGoogle Scholar
  38. 38.
    Santisteban DA, Szapocznik J, Perez-Vidal A, Kurtines WM, Murray EJ, Laperriere A. Efficacy of intervention for engaging youth and families into treatment and some variables that may contribute to differential effectiveness. Fam Syst Health. 1996;10:35–44.Google Scholar
  39. 39.
    Coatsworth JD, Santisteban DA, McBride CK, Szapocznik J. Brief strategic family therapy versus community control: engagement, retention and an exploration of the moderating role of adolescent symptom severity. Fam Process. 2001;40:313–32.CrossRefPubMedGoogle Scholar
  40. 40.
    Mitrani VB, Weiss-Laxer NS, Ow CE, Burns MJ, Ross-Russell S, Feaster DJ. Examining family networks of HIV+ women in drug recovery: challenges and opportunities. Fam Syst Health. 2009;27:267–83.CrossRefPubMedGoogle Scholar
  41. 41.
    Williams J. Structured interview guide for the Hamilton depression and anxiety scales (SIGH-AD). New York: New York State Psychiatric Institute; 1988.Google Scholar
  42. 42.
    Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5.PubMedGoogle Scholar
  43. 43.
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.CrossRefPubMedGoogle Scholar
  44. 44.
    McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: measurement and sample profiles. Psychother Theory Res Pract. 1983;20:368–75.CrossRefGoogle Scholar
  45. 45.
    DeLongis A, Folkman S, Lazarus RS. The impact of daily stress on health and mood: psychosocial and social resources as mediators. J Pers Soc Psychol. 1988;54:486–95.CrossRefPubMedGoogle Scholar
  46. 46.
    Sarason IG, Sarason BR, Shearin EN, Pierce GR. A brief measure of social support: practical and theoretical implications. J Soc Pers Relatsh. 1987;4:497–510.CrossRefGoogle Scholar
  47. 47.
    Szapocznik J, Rio AT, Hervis OE, Mitrani VB, Kurtines WM, Faraci AM. Assessing change in family functioning as a result of treatment: the structural family systems rating scale (SFSR). J Marital Fam Ther. 1991;17:295–310.CrossRefGoogle Scholar
  48. 48.
    Mitrani VB, Feaster DJ, McCabe BE, Czaja SJ, Szapocznik J. Adapting the structural family systems rating to assess the patterns of interaction in families of dementia caregivers. Gerontologist. 2005;45:445–55.PubMedGoogle Scholar
  49. 49.
    Minuchin S, Rosman BL, Baker L. Psychosomatic families: anorexia nervosa in context. Cambridge: Harvard University Press; 1978.Google Scholar
  50. 50.
    Muthén LK, Muthén BO. Mplus user’s guide. 5th ed. Los Angeles: Muthén and Muthén; 2007.Google Scholar
  51. 51.
    Bryan A, Schiege SJ, Broaddus MR. Mediational analysis in HIV/AIDS research: estimating multivariate path analytic models in a structural equation modeling framework. AIDS Behav. 2007;11:365–83.CrossRefPubMedGoogle Scholar
  52. 52.
    Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18:39–50.CrossRefGoogle Scholar
  53. 53.
    Liddle HA, Dakof GA. Efficacy of family therapy for drug abuse: promising but not definitive. J Marital Fam Ther. 1995;21:511–43.CrossRefGoogle Scholar
  54. 54.
    West SG, Duan N, Pequegnat W, et al. Alternatives to the randomized controlled trial. Am J Public Health. 2008;98:1359–66.CrossRefPubMedGoogle Scholar
  55. 55.
    Center for the Integration of Research & Practice [homepage on the Internet]. New York: National Development and Research Institutes, Inc. 2004. Accessed Mar 29, 2010.
  56. 56.
    Rotheram-Borus MJ, Lester P, Song J, et al. Intergenerational benefits of family-based HIV interventions. J Consult Clin Psychol. 2006;74:622–7.CrossRefPubMedGoogle Scholar
  57. 57.
    Boyd-Franklin N. Black families in therapy: a multisystems approach. New York: Guilford Press; 1989.Google Scholar
  58. 58.
    Ledgerwood DM, Alessi SM, Hason T, Godley MD, Petry NM. Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics. J Appl Behav Anal. 2008;41:517–26.CrossRefPubMedGoogle Scholar
  59. 59.
    Nock MK, Kazdin AE. Randomized controlled trial of a brief intervention for increasing participation in parent management training. J Consult Clin Psychol. 2005;73:872–9.CrossRefPubMedGoogle Scholar
  60. 60.
    Swartz HA, Zuckoff A, Grote N, et al. Engaging depressed patients in psychotherapy: integrating techniques from motivational interviewing and ethnographic interviewing to improve treatment participation. Prof Psychol Res Pract. 2007;38:430–9.CrossRefGoogle Scholar
  61. 61.
    Golin CE, Earp J, Tien H, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42–51.CrossRefPubMedGoogle Scholar
  62. 62.
    Parsons JT, Rosof E, Punzalan JC, DiMaria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDS. 2005;19:31–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Victoria B. Mitrani
    • 1
  • Daniel J. Feaster
    • 2
  • Nomi S. Weiss-Laxer
    • 1
  • Brian E. McCabe
    • 1
  1. 1.Center of Excellence for Health Disparities Research: El Centro, School of Nursing and Health StudiesUniversity of MiamiCoral GablesUSA
  2. 2.Department of Epidemiology and Public Health, Leonard M. Miller School of MedicineUniversity of MiamiMiamiUSA

Personalised recommendations